GERD: Causes, Symptoms, and Long-Term Treatment

An estimated 20 percent of the U.S. adult population experiences gastroesophageal reflux symptoms weekly, making GERD one of the most prevalent gastrointestinal conditions in the Western world. Yet many people dismiss chronic heartburn as a minor inconvenience, not realizing that persistent GERD can damage the esophageal lining and, over time, increase the risk of more serious complications. The condition is highly treatable – but effective management depends on understanding what drives it and which strategies offer lasting relief rather than temporary fixes. For a broader view of common health conditions, visit our medical conditions guide.

What Is GERD?

Gastroesophageal reflux disease (GERD) occurs when stomach acid frequently flows back into the esophagus – the tube connecting the mouth to the stomach. This backward flow, called acid reflux, irritates the esophageal lining, which lacks the protective mucus coating that shields the stomach. While occasional acid reflux is normal, the American College of Gastroenterology defines GERD as reflux that occurs more than twice a week or causes troublesome symptoms or complications.

The lower esophageal sphincter (LES) – a ring of muscle at the junction of the esophagus and stomach – normally acts as a one-way valve, opening to allow food into the stomach and closing to prevent backflow. In GERD, the LES relaxes inappropriately or is structurally weakened, allowing acid and sometimes bile to reflux upward. The result is inflammation of the esophageal tissue, a condition called esophagitis.

GERD is a chronic condition for most patients. While symptoms can wax and wane, the underlying dysfunction – whether it is a weak LES, a hiatal hernia, or impaired esophageal clearance – tends to persist. This is why long-term management strategies, rather than short-term fixes, are central to effective treatment.

Causes and Risk Factors

The pathophysiology of GERD involves multiple mechanisms. The most common is transient lower esophageal sphincter relaxation (TLESR) – brief episodes where the LES relaxes independent of swallowing, allowing acid to reflux. A hiatal hernia, in which part of the stomach protrudes above the diaphragm, disrupts the normal anti-reflux barrier and is present in the majority of patients with moderate to severe GERD.

According to the NIDDK, several factors increase GERD risk. Obesity – particularly central abdominal obesity – raises intra-abdominal pressure and mechanically disrupts the LES. Pregnancy causes GERD through both hormonal effects (progesterone relaxes the LES) and physical pressure from the growing uterus. Smoking weakens the LES and reduces saliva production, which normally helps neutralize refluxed acid.

Certain medications can exacerbate GERD, including calcium channel blockers, anticholinergics, benzodiazepines, theophylline, and some antidepressants. Dietary triggers vary by individual but commonly include fatty foods, chocolate, caffeine, alcohol, citrus, tomato-based products, mint, and spicy foods. Eating large meals, eating close to bedtime, and lying down after meals all increase reflux episodes.

Symptoms Beyond Heartburn

Heartburn – a burning sensation rising from the upper abdomen or lower chest toward the neck – is the classic GERD symptom. Regurgitation, the sensation of acid or food backing up into the throat or mouth, is the second most common complaint. Together, these “typical” symptoms are highly suggestive of GERD when they occur regularly.

However, GERD can present with a range of “atypical” or extraesophageal symptoms that are often misattributed to other conditions. Chronic cough, particularly a dry cough that worsens at night or after meals, is one of the top three causes of chronic cough in adults. Laryngopharyngeal reflux (LPR), sometimes called “silent reflux,” causes hoarseness, throat clearing, a sensation of a lump in the throat (globus), and sore throat without classic heartburn. Asthma can be triggered or worsened by GERD – the Mayo Clinic notes a strong association between adult asthma and GERD.

Chest pain from GERD can be so severe that it mimics a heart attack – this is called non-cardiac chest pain and is one of the most common reasons for emergency department visits. It is critical, though, that a heart cause be ruled out first: never assume chest pain is reflux on your own. Dental erosion, particularly on the inner surfaces of the upper teeth, is another underrecognized consequence of chronic acid reflux. Sleep disturbances, including fragmented sleep and worsened obstructive sleep apnea, are also associated with nighttime GERD.

Diagnosis: When and How

For patients with typical GERD symptoms (heartburn and regurgitation) who respond to a trial of acid-suppressive therapy, a diagnosis can often be made clinically without invasive testing. An 8-week trial of a proton pump inhibitor (PPI) that results in symptom improvement supports the diagnosis.

Upper endoscopy (EGD) is recommended when symptoms do not respond to therapy, when alarm symptoms are present (difficulty swallowing, unintentional weight loss, GI bleeding, anemia, persistent vomiting), or to screen for Barrett’s esophagus in higher-risk individuals. During endoscopy, the physician can directly visualize the esophageal mucosa, assess for esophagitis, strictures, or Barrett’s changes, and take biopsies. Notably, more than half of GERD patients have a normal-appearing esophagus on endoscopy – this is called non-erosive reflux disease (NERD).

Ambulatory pH monitoring – either wireless (Bravo capsule) or catheter-based – is the gold standard for quantifying acid exposure in the esophagus over 24 to 96 hours. This test is particularly useful before anti-reflux surgery, in patients with persistent symptoms despite therapy, and when the diagnosis is uncertain. Esophageal manometry measures the pressure and coordination of esophageal muscle contractions and LES function, and is generally required before surgical intervention to rule out motility disorders.

Lifestyle Modifications That Work

Lifestyle changes are the foundation of GERD management and can significantly reduce symptoms for many patients. The modifications with the strongest evidence base, reflected in the ACG guideline, include weight loss for overweight or obese patients (even modest weight loss of 5 to 10 percent can improve symptoms), elevating the head of the bed 6 to 8 inches (using a wedge or blocks under the bedposts – not just extra pillows), and avoiding meals within 2 to 3 hours of bedtime.

Identifying and avoiding personal dietary triggers is helpful, though there is no universal “GERD diet” supported by strong evidence. Some patients benefit from reducing portion sizes, eating more slowly, and avoiding carbonated beverages. Smoking cessation is strongly recommended, as smoking both weakens the LES and reduces salivary bicarbonate, which normally helps neutralize refluxed acid.

Wearing loose-fitting clothing around the waist, avoiding bending over or vigorous exercise immediately after meals, and sleeping on the left side (which positions the stomach below the esophagus) are additional strategies that some patients find helpful. While lifestyle changes alone may not fully control moderate to severe GERD, they can reduce the medication dose needed and improve overall quality of life.

Medical Treatment Options

Antacids (such as Tums, Maalox, and Mylanta) provide rapid but short-lived relief by neutralizing stomach acid. They are appropriate for occasional, mild symptoms but do not heal esophagitis or control frequent GERD. H2 receptor antagonists – famotidine (Pepcid) is now the most commonly used, after ranitidine (Zantac) was withdrawn from the U.S. market over an impurity concern – reduce acid secretion and can help mild to moderate GERD, particularly nighttime symptoms.

Proton pump inhibitors (PPIs) are the most established and effective medical therapy for GERD. Omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole suppress acid production by blocking the proton pump in the stomach’s parietal cells. According to the American College of Gastroenterology, PPIs heal erosive esophagitis in the large majority of patients within about 8 weeks and are superior to H2 blockers for both symptom control and mucosal healing. PPIs generally work best taken about 30 to 60 minutes before a meal.

A newer class of acid suppressant is now available: potassium-competitive acid blockers (P-CABs). Vonoprazan (brand name Voquezna) is the first FDA-approved P-CAB in the United States; it blocks acid production by a different mechanism than PPIs, produces faster and more sustained acid suppression, and can be taken with or without food. It is FDA-approved to heal and maintain healing of erosive esophagitis and, separately, to relieve heartburn in non-erosive GERD, as well as (in combination regimens) to help eradicate H. pylori. Whether a P-CAB or a PPI is the better choice is an individualized decision to make with your clinician.

For patients who need ongoing acid suppression, the goal is the lowest effective dose. Concerns about long-term PPI use – including possible associations with kidney disease, bone fractures, Clostridioides difficile infection, and micronutrient deficiencies (such as vitamin B12 and magnesium) – come largely from observational studies, and the American Gastroenterological Association emphasizes that for patients with a clear indication, the benefits generally outweigh these risks. Importantly, do not stop a long-term PPI abruptly: rebound acid hypersecretion can cause a temporary flare of heartburn that feels worse than before. If you and your clinician decide to stop, a gradual taper (sometimes bridging with an H2 blocker or antacids) makes it far more tolerable. Regular reassessment of the need for ongoing therapy is recommended.

Surgical and Procedural Options

For patients who respond to acid suppression but prefer not to take lifelong medication, or for those with persistent symptoms despite maximum medical therapy, anti-reflux surgery is an option. The standard procedure is laparoscopic Nissen fundoplication, in which the upper portion of the stomach is wrapped around the lower esophagus to reinforce the LES. This procedure succeeds in roughly 85 to 90 percent of carefully selected patients, with most able to discontinue or significantly reduce acid-suppressive medication.

Magnetic sphincter augmentation (the LINX device) is a newer surgical option that places a ring of small magnetic beads around the LES. The magnets are strong enough to prevent reflux but weak enough to allow food to pass through during swallowing. Studies show outcomes comparable to Nissen fundoplication with potentially fewer side effects such as gas-bloat and difficulty belching.

Endoscopic treatments, including transoral incisionless fundoplication (TIF), offer a less invasive alternative to surgery. TIF creates a partial wrap of the stomach around the esophagus using a device inserted through the mouth, without external incisions. While outcomes are generally good for appropriately selected patients, the long-term durability of endoscopic approaches is still being studied. Choosing between these options should be a shared decision between you and a gastroenterologist or surgeon experienced in these procedures, factoring in treatment costs alongside clinical considerations.

Complications of Chronic GERD

Untreated or poorly controlled GERD can lead to several important complications. Erosive esophagitis – visible damage to the esophageal lining – can cause pain, bleeding, and difficulty swallowing. Esophageal strictures form when chronic inflammation leads to scarring and narrowing of the esophagus, causing progressive difficulty swallowing solid foods. These can often be treated with endoscopic dilation.

Barrett’s esophagus is the most significant complication from a cancer-risk standpoint. In this condition, chronic acid exposure causes the normal squamous cell lining of the lower esophagus to be replaced by specialized intestinal-type columnar epithelium – a process called intestinal metaplasia. According to the National Cancer Institute, Barrett’s esophagus substantially increases the relative risk of esophageal adenocarcinoma compared to the general population, though the absolute annual risk remains low (on the order of 0.5 percent per year without dysplasia).

Patients with Barrett’s esophagus require regular endoscopic surveillance to detect dysplasia (pre-cancerous changes). If dysplasia is found, endoscopic treatments such as radiofrequency ablation or endoscopic mucosal resection can effectively eliminate the abnormal tissue. Screening for Barrett’s is generally considered in patients with chronic GERD symptoms (more than 5 years) who also have additional risk factors: male sex, age over 50, White race, obesity, smoking history, or family history of Barrett’s or esophageal cancer.

Frequently Asked Questions

What is the difference between acid reflux and GERD?

Acid reflux is the physical event of stomach contents flowing backward into the esophagus. Occasional acid reflux is normal and happens to virtually everyone. GERD is the chronic condition diagnosed when acid reflux occurs frequently enough to cause troublesome symptoms or complications. Think of acid reflux as an event and GERD as a disease. If you experience heartburn or regurgitation more than twice per week, or if reflux is affecting your quality of life, you may have GERD.

Can GERD be cured permanently?

For most patients, GERD is a chronic condition that can be effectively managed but not “cured” in the traditional sense. Lifestyle modifications and weight loss can reduce or eliminate symptoms in some mild cases. Anti-reflux surgery (fundoplication or magnetic sphincter augmentation) provides long-term symptom control for many patients, though some may eventually need to resume some level of medication. The underlying factors – such as a hiatal hernia or a naturally weak LES – tend to persist, which is why ongoing management rather than cure is the appropriate framework for most people.

Is it safe to take a PPI long-term?

For patients with a clear indication – such as erosive esophagitis, Barrett’s esophagus, or persistent symptoms that significantly impair quality of life – long-term acid suppression is considered appropriate by major gastroenterology organizations. Potential risks reported in observational studies (bone fractures, kidney problems, infections, low B12 or magnesium) are generally small in absolute terms and may be influenced by confounding factors. The key is to use the lowest effective dose, reassess the need periodically, and taper rather than stop abruptly to avoid rebound heartburn.

Can GERD cause cancer?

Chronic GERD is a risk factor for Barrett’s esophagus, which in turn increases the risk of esophageal adenocarcinoma. However, most people with GERD never develop Barrett’s, and most people with Barrett’s never develop cancer. The annual progression rate from Barrett’s without dysplasia to cancer is roughly 0.5 percent. Proper management of GERD – including acid suppression and, for those with Barrett’s, regular endoscopic surveillance – helps mitigate this risk.

Why does my GERD get worse at night?

Several factors contribute to nighttime GERD. Lying flat removes the gravitational advantage that helps keep stomach contents down during the day. Swallowing, which normally clears acid from the esophagus, occurs less frequently during sleep. Salivary production, which neutralizes acid, also decreases at night. Eating close to bedtime means the stomach is still actively producing acid when you lie down. Elevating the head of your bed 6 to 8 inches and avoiding food within 2 to 3 hours of sleep are the most effective strategies for nighttime reflux.

Taking Charge of Your Reflux

GERD is a condition where proactive management pays measurable dividends. If you are relying on antacids multiple times a week or experiencing symptoms that disrupt your sleep, eating, or daily activities, it is time for a conversation with your doctor – not a stronger antacid from the drugstore. A proper evaluation can determine whether you have GERD, assess for complications, and establish an appropriate treatment plan.

Start with the lifestyle modifications that have the strongest evidence: lose weight if you are carrying extra pounds, elevate the head of your bed, and stop eating 2 to 3 hours before lying down. These cost nothing and can make a meaningful difference. If medication is needed, take it as directed – acid blockers work best when taken consistently as prescribed, not just as-needed after symptoms start – and do not stop a long-term acid blocker abruptly.

Most importantly, do not ignore progressive symptoms. New or worsening difficulty swallowing, unintentional weight loss, persistent vomiting, or GI bleeding warrant prompt medical evaluation, and chest pain with sweating or radiation to the arm or jaw is a 911 emergency until a heart cause is ruled out. With appropriate management, the vast majority of people with GERD can achieve good symptom control and prevent long-term complications.

Sources

• American College of Gastroenterology – Clinical Guideline: Diagnosis and Management of Gastroesophageal Reflux Disease (2022) and patient resources
• NIDDK (National Institute of Diabetes and Digestive and Kidney Diseases) – Acid Reflux (GER & GERD) in Adults
• Mayo Clinic – GERD: Symptoms and Causes
• American Gastroenterological Association – guidance on long-term PPI use
• U.S. Food and Drug Administration – vonoprazan (Voquezna) prescribing information and approvals
• National Cancer Institute – Esophageal Cancer and Barrett’s esophagus